A first in human proof of concept phase I clinical study of VAS-101 (Vasceptor®; topical curcumin gel) in sickle cell disease (SCD) is underway. The study is being conducted by the Foundation for Sickle Cell Disease Research (FSCDR) in Hollywood, Florida, under the supervision of the principal investigator, Dr. Gershwin Blyden.
AdventHealth Tampa is the first in the Tampa Bay area to offer a powerful new pump-based treatment option for colorectal cancer that has spread to the liver and for a rare form of cancer that forms in bile ducts within the liver called intrahepatic cholangiocarcinoma.
Stryker a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons.
Since 2010, the NEXTY Awards have honored the highest quality natural products in the world. This year, Qualia Life Sciences is the only supplement brand to have two products, Qualia NAD+ and Qualia Mind.
Royal Philips a global leader in health technology, Amerigroup, CareSource Georgia, and Peach State Health Plan have partnered to provide remote monitoring solutions to expand access to quality healthcare for high-risk pregnancies in the state.
AI/ML health tech startup Respiree has received clearance from the Health Sciences Authority (HSA) to extend its RS001 cardio-respiratory wearable to pediatric populations. This clearance also enables the extension of Respiree's software platform, introducing enterprise-grade pathway management services and EHR interoperability which further enhances its innovative healthcare solutions.
TOOsonix A/S, a leader in high-intensity focused ultrasound technology for dermatology, has partnered with MikronMed AB, a top distributor of medical equipment in the Nordic region. The collaboration will bring TOOsonix innovative MDR CE marked systems to healthcare professionals in the Nordic region.
Medit a global leader in digital dentistry, is set to revolutionize the digital All-on-X workflow, making it more accessible, efficient, and intuitive for Medit scanner users.
An updated standard compiled by the Association for the Advancement of Medical Instrumentation (AAMI) and adopted by the American National Standards Institute (ANSI) has acknowledged chlorine dioxide foam as a novel modality for high-level disinfection of medical devices.
CREAL's next-generation light field display developed for Augmented Reality (AR) glasses is now ready for integration. By replicating real-world light to deliver genuine focus depth, the display uniquely provides complete and correct 3D perception for an entirely natural, comfortable, and healthy visual experience in AR. The display is compatible with conventional prescription lenses, offering precise vision correction while maintaining high transparency to ensure clear view, eye contact, and social comfort.